Adrian M. Di Bisceglie, MD——Chief Medical Officer

Dr. Adrian M. Di Bisceglie is Chief Medical Officer of HighTide. Dr. Di Bisceglie is board-certified in internal medicine, gastroenterology and transplant hepatology. A thought leader in hepatology, Dr. Di Bisceglie has authored over 400 publications. He is the past president (2014) and governing board member (2010-2015) of the American Association for the Study of Liver Disease (AASLD). Dr. Di Bisceglie has served as a member of the editorial board of the AASLD journal “Hepatology”. Additionally, he has served as an advisor and committee member with the US FDA, CDC, and NIH. Most recently Dr. Di Bisceglie served as Professor of Internal Medicine and Chief of Hepatology, Division of Gastroenterology and Hepatology at Saint Louis University. He also served as Chairman, Department of Internal Medicine at Saint Louis University from 2006 to 2017. In this academic and business leadership capacity, he oversaw an organization with 600 employees and managed a clinical and research budget of over $100M annually.

Dr. Di Bisceglie received his Bachelor of Medicine and Bachelor of Surgery (MB BCh), and Master of Medicine in Internal Medicine (M. Med) from the University of the Witwatersrand, Johannesburg, South Africa.


We will contact you as soon as possible

© 2020 HighTide Therapeutics Inc.

Legal StatementPrivacy PolicyCookie Policy


Follow Us

© 2020 HighTide Therapeutics Inc.